C16 globotriaosylceramide is an endogenous sphingolipid found in mammalian cell membranes that is synthesized from C16 lactosylceramide . C16 globotriaosylceramide acts as a receptor for Shiga toxin in B cell-derived Raji cells and THP-1 monocytes. It accumulates in endothelial cells, pericytes, vascular smooth muscle cells, renal epithelial cells, dorsal ganglia neuronal cells, and myocardial cells in patients with Fabry disease. C16 globotriaosylceramide is also upregulated in plasma of patients with ovarian carcinoma compared to those with benign ovarian tumors or uterine fibroids.

137896-85-6

C52H97NO18

1024.32

C16 Globotriaosylceramide (d18:1/16:0);C16 Globotriaosylceramide (d18:1/16:0)

DMSO:Soluble
Methanol:Warmed
Chloroform:Methanol (2:1):Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years